Novo Nordisk A/S
Stock Forecast, Prediction & Price Target
Novo Nordisk A/S Financial Estimates
Novo Nordisk A/S Revenue Estimates
Novo Nordisk A/S EBITDA Estimates
Novo Nordisk A/S Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $140.8B N/A | $176.95B 25.67% | $232.26B 31.25% | Avg: $345.97B Low: $340.05B High: $349.40B avg. 48.96% | Avg: $400.09B Low: $378.71B High: $417.81B avg. 15.64% | Avg: $439.67B Low: $416.17B High: $459.14B avg. 9.89% | Avg: $483.42B Low: $457.58B High: $504.83B avg. 9.95% |
Net Income
% change YoY
| $47.75B N/A | $55.52B 16.26% | $83.68B 50.71% | Avg: $128.13B Low: $112.04B High: $138.56B avg. 53.12% | Avg: $152.59B Low: $141.99B High: $161.38B avg. 19.08% | Avg: $165.91B Low: $154.38B High: $175.46B avg. 8.72% | Avg: $181.98B Low: $169.33B High: $192.45B avg. 9.68% |
EBITDA
% change YoY
| $67.55B N/A | $82.04B 21.43% | $114.62B 39.72% | Avg: $164.52B Low: $161.70B High: $166.14B avg. 43.52% | Avg: $190.25B Low: $180.08B High: $198.68B avg. 15.64% | Avg: $209.07B Low: $197.90B High: $218.33B avg. 9.89% | Avg: $229.88B Low: $217.59B High: $240.06B avg. 9.95% |
EPS
% change YoY
| $10.4 N/A | $12.26 17.88% | $18.62 51.87% | Avg: $28.51 Low: $24.93 High: $30.83 avg. 53.10% | Avg: $33.95 Low: $31.59 High: $35.9 avg. 19.08% | Avg: $36.91 Low: $34.35 High: $39.04 avg. 8.72% | Avg: $40.49 Low: $37.67 High: $42.82 avg. 9.68% |
Operating Expenses
% change YoY
| $58.49B N/A | $73.69B 25.98% | $93.92B 27.44% | Avg: $98.77B Low: $97.08B High: $99.74B avg. 5.16% | Avg: $114.22B Low: $108.11B High: $119.28B avg. 15.64% | Avg: $125.52B Low: $118.81B High: $131.07B avg. 9.89% | Avg: $138.01B Low: $130.63B High: $144.12B avg. 9.95% |
FAQ
What is Novo Nordisk A/S stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.65% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is 112.04B, average is 128.13B and high is 138.56B.
What is Novo Nordisk A/S stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.11% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $340.05B, average is $345.97B and high is $349.40B.
What is Novo Nordisk A/S stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 22.65% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is $24.93, average is $28.51 and high is $30.82.
What is the best performing analyst?
In the last twelve months analysts have been covering Novo Nordisk A/S stock. The most successful analyst is Evan Seigerman.